175 related articles for article (PubMed ID: 20706133)
1. Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade.
Ihara G; Kiyomoto H; Kobori H; Nagai Y; Ohashi N; Hitomi H; Nakano D; Pelisch N; Hara T; Mori T; Ito S; Kohno M; Nishiyama A
J Hypertens; 2010 Nov; 28(11):2289-98. PubMed ID: 20706133
[TBL] [Abstract][Full Text] [Related]
2. Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats.
Sofue T; Kiyomoto H; Kobori H; Urushihara M; Nishijima Y; Kaifu K; Hara T; Matsumoto S; Ichimura A; Ohsaki H; Hitomi H; Kawachi H; Hayden MR; Whaley-Connell A; Sowers JR; Ito S; Kohno M; Nishiyama A
Am J Hypertens; 2012 May; 25(5):604-11. PubMed ID: 22318512
[TBL] [Abstract][Full Text] [Related]
3. Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.
Nishiyama A; Nakagawa T; Kobori H; Nagai Y; Okada N; Konishi Y; Morikawa T; Okumura M; Meda I; Kiyomoto H; Hosomi N; Mori T; Ito S; Imanishi M
J Hypertens; 2008 Sep; 26(9):1849-59. PubMed ID: 18698221
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats.
Nishiyama A; Kobori H; Konishi Y; Morikawa T; Maeda I; Okumura M; Kishida M; Hamada M; Nagai Y; Nakagawa T; Ohashi N; Nakano D; Hitomi H; Imanishi M
J Pharmacol Exp Ther; 2010 Mar; 332(3):1072-80. PubMed ID: 19940106
[TBL] [Abstract][Full Text] [Related]
5. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.
Kakimoto T; Okada K; Hirohashi Y; Relator R; Kawai M; Iguchi T; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
J Endocrinol; 2014 Jul; 222(1):43-51. PubMed ID: 24781258
[TBL] [Abstract][Full Text] [Related]
6. CS-886, a new angiotensin II type 1 receptor antagonist, ameliorates glomerular anionic site loss and prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats.
Koga K; Yamagishi S; Takeuchi M; Inagaki Y; Amano S; Okamoto T; Saga T; Makita Z; Yoshizuka M
Mol Med; 2002 Oct; 8(10):591-9. PubMed ID: 12477969
[TBL] [Abstract][Full Text] [Related]
7. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-δ activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in type 2 diabetes.
Lee EY; Kim GT; Hyun M; Kim S; Seok S; Choi R; Lee MY; Chung CH
Nephrol Dial Transplant; 2012 Nov; 27(11):4069-79. PubMed ID: 22892126
[TBL] [Abstract][Full Text] [Related]
9. Improvements in diabetic albuminuria and podocyte differentiation following Roux-en-Y gastric bypass surgery.
Canney AL; Cohen RV; Elliott JA; M Aboud C; Martin WP; Docherty NG; le Roux CW
Diab Vasc Dis Res; 2020; 17(1):1479164119879039. PubMed ID: 31726864
[TBL] [Abstract][Full Text] [Related]
10. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy.
Weil EJ; Lemley KV; Mason CC; Yee B; Jones LI; Blouch K; Lovato T; Richardson M; Myers BD; Nelson RG
Kidney Int; 2012 Nov; 82(9):1010-7. PubMed ID: 22718189
[TBL] [Abstract][Full Text] [Related]
11. Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation.
Rafiq K; Noma T; Fujisawa Y; Ishihara Y; Arai Y; Nabi AH; Suzuki F; Nagai Y; Nakano D; Hitomi H; Kitada K; Urushihara M; Kobori H; Kohno M; Nishiyama A
Circulation; 2012 Mar; 125(11):1402-13. PubMed ID: 22328542
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
Advani A; Wiggins KJ; Cox AJ; Zhang Y; Gilbert RE; Kelly DJ
Nephrology (Carlton); 2011 Aug; 16(6):573-81. PubMed ID: 21342330
[TBL] [Abstract][Full Text] [Related]
13. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease.
Menini S; Iacobini C; Oddi G; Ricci C; Simonelli P; Fallucca S; Grattarola M; Pugliese F; Pesce C; Pugliese G
Diabetologia; 2007 Dec; 50(12):2591-9. PubMed ID: 17901943
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
[TBL] [Abstract][Full Text] [Related]
15. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
16. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.
Gross ML; El-Shakmak A; Szábó A; Koch A; Kuhlmann A; Münter K; Ritz E; Amann K
Diabetologia; 2003 Jun; 46(6):856-68. PubMed ID: 12802493
[TBL] [Abstract][Full Text] [Related]
17. Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte Apoptosis.
Gu J; Yang M; Qi N; Mei S; Chen J; Song S; Jing Y; Chen M; He L; Sun L; Hu H; Li L; Wüthrich RP; Wu M; Mei C
Kidney Blood Press Res; 2016; 41(6):848-864. PubMed ID: 27871084
[TBL] [Abstract][Full Text] [Related]
18. Podocyte hypertrophic stress and detachment precedes hyperglycemia or albuminuria in a rat model of obesity and type2 diabetes-associated nephropathy.
Minakawa A; Fukuda A; Sato Y; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
Sci Rep; 2019 Dec; 9(1):18485. PubMed ID: 31811176
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.
Fukuda A; Wickman LT; Venkatareddy MP; Sato Y; Chowdhury MA; Wang SQ; Shedden KA; Dysko RC; Wiggins JE; Wiggins RC
Kidney Int; 2012 Jan; 81(1):40-55. PubMed ID: 21937979
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
